Peer Review reports
From: Relating mutational signature exposures to clinical data in cancers via signeR 2.0
| Original Submission | ||
|---|---|---|
| 24 Aug 2023 | Submitted | Original manuscript |
| 31 Aug 2023 | Author responded | Author comments - Israel Tojal Silva |
| 25 Sep 2023 | Reviewed | Reviewer Report - Haoyang Cai |
| 3 Oct 2023 | Reviewed | Reviewer Report |
| 18 Oct 2023 | Author responded | Author comments - Israel Tojal Silva |
| Resubmission - Version 2 | ||
| 31 Aug 2023 | Submitted | Manuscript version 2 |
| 19 Oct 2023 | Author responded | Author comments - Israel Tojal Silva |
| Resubmission - Version 3 | ||
| 19 Oct 2023 | Submitted | Manuscript version 3 |
| 25 Oct 2023 | Reviewed | Reviewer Report - Haoyang Cai |
| 26 Oct 2023 | Reviewed | Reviewer Report |
| Resubmission - Version 4 | ||
| Submitted | Manuscript version 4 | |
| Publishing | ||
| 27 Oct 2023 | Editorially accepted | |
| 22 Nov 2023 | Article published | 10.1186/s12859-023-05550-3 |
You can find further information about peer review here.